Provided by Tiger Trade Technology Pte. Ltd.

Adaptive Biotechnologies Corp

13.17
+0.72005.78%
Post-market: 13.250.0800+0.61%18:56 EDT
Volume:3.90M
Turnover:50.85M
Market Cap:2.03B
PE:-33.58
High:13.28
Open:13.05
Low:12.69
Close:12.45
52wk High:20.76
52wk Low:6.68
Shares:153.78M
Float Shares:117.37M
Volume Ratio:1.28
T/O Rate:3.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3922
EPS(LYR):-0.3922
ROE:-27.82%
ROA:-6.79%
PB:9.26
PE(LYR):-33.58

Loading ...

Adaptive meldet für das Gesamtjahr einen Nettoverlust von 159,49 Mio. USD, ein Anstieg um 169 Prozent

Reuters
·
Feb 06

BRIEF-Adaptive Biotechnologies Q4 EPS USD -0.09

Reuters
·
Feb 06

Adaptive Biotechnologies: Expects FY Revenue for Mrd Business to Be Between $255 Million - $265 Million

THOMSON REUTERS
·
Feb 06

Adaptive Biotechnologies: Expect FY Operating Expenses, Including Cost of Revenue, to Be Between $350 Mln - $360 Mln

THOMSON REUTERS
·
Feb 06

Stock Track | Adaptive Biotechnologies Plunges 10.40% in Pre-Market on Earnings Anticipation

Stock Track
·
Feb 05

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 05

Adaptive Biotechnologies CEO Chad M. Robins Reports Sale of Common Shares

Reuters
·
Feb 05

Earning Preview: Adaptive Biotechnologies Corp’s revenue is expected to increase by 29.02%, and institutional views are cautiously optimistic

Earnings Agent
·
Jan 29

Adaptive Biotechnologies to Participate in BTIG and TD Cowen Investor Conferences

Reuters
·
Jan 28

Adaptive Biotechnologies Is Maintained at Buy by Guggenheim

Dow Jones
·
Jan 27

Adaptive Biotechnologies Corporation to Report Financial Results

Reuters
·
Jan 23

CFO Kyle Piskel Reports Disposal of Adaptive Biotechnologies Common Shares

Reuters
·
Jan 15

What's Going On With Adaptive Biotechnologies Shares Tuesday?

Benzinga_recent_news
·
Jan 13

Adaptive Biotechnologies Shares Rise on Preliminary Earnings

Dow Jones
·
Jan 12

Adaptive Biotechnologies Shares up 11.4% Premarket After Co Announces Preliminary Q4, FY25 Results

THOMSON REUTERS
·
Jan 12

Adaptive Biotechnologies Corp - Preliminary Q4 Revenue $72 Mln

THOMSON REUTERS
·
Jan 12

Press Release: Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results

Dow Jones
·
Jan 12

The Bull Case For Adaptive Biotechnologies (ADPT) Could Change Following New Pfizer Immune-Data Deals And Spinout Financing – Learn Why

Simply Wall St.
·
Jan 11

Assessing Adaptive Biotechnologies (ADPT) Valuation After New Pfizer Deals And Digital Biotechnologies Financing

Simply Wall St.
·
Jan 09

CEO and Chairman Chad M. Robins Reports Sale of Adaptive Biotechnologies Common Shares

Reuters
·
Jan 08